Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial

Oncologist · Published 2026-06-29 · DOI 10.1093/oncolo/oyag250

Free full text

Authors (18)

Thomas J. George, Tuo Lin, Ibrahim Nassour, Sherise C Rogers, Tim Jang, I. Sahin, Brian H Ramnaraign, Jesus Fabregas, Kathryn Hitchcock, Gonghao Liu, Karen B Russell, Anita A Turk, Omar Kayaleh, Z Hugh Fan, David L DeRemer, Ryan M Thomas, Ji-Hyun Lee, Steven J Hughes

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

George, T., Lin, T., Nassour, I., et al. (2026). Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial. Oncologist. https://doi.org/10.1093/oncolo/oyag250

Related articles